Editorial content

Our September 2017 edition is live!

Our September 2017 edition includes an immuno-oncology update, a market forecast of antibody-drug conjugates and a spotlight on women's health.

Go to the profile of Raveena Bhambra
Sep 01, 2017
1
0
Upvote 1 Comment

Read our September 2017 issue now.

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.
29 Contributions
97 Followers
21 Following

No comments yet.